Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE To examine the reliability and validity of the Geriatric Depression Scale-15 (GDS-15) and the Patient Health Questionnaire-9 (PHQ-9) for evaluating depression in older adults. 31820572 2020
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE To evaluate the diagnostic accuracy of a short depression screening tool, the Saint Louis University (SLU) AMSAD depression scale, relative to the Geriatric Depression Scale-15 (GDS-15) and Montgomery-Asberg Depression Rating Scale (MADRS), and in relation to the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) criteria for major depressive disorder, in cognitively intact older adults. 31704225 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE Trained nurses (field interviewers) administered structured questionnaires that included a validated Nepali version of the Geriatric Depression Scale short form (GDS-15) for identifying geriatric depression among the elderly (≥60 years) participants (N = 460). 31481037 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The 15-item Geriatric Depression Scale (GDS-15) is widely used to screen depression among elders. 31293470 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE GDS-3A items were strongly connected to each other and with varying strength to several GDS-12D items. 30782219 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE Frailty (vs. pre-frail status) was associated with a significantly worse SPPB score (5 ± 2.2 vs. 7 ± 2.4, respectively), 6-MWT distance (143 ± 79 m vs. 221 ± 99 m, respectively), QoL (35 ± 19 vs. 46 ± 21, respectively), and more depression (GDS score: 5.5 ± 3.5 vs. 4.2 ± 3.3, respectively) but similar cognition. 31779931 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE Symptoms of depression were assessed using the 15-item Geriatric Depression Scale (GDS-15). 31190776 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The present study suggests that there is a higher prevalence of anxiety and somatic symptoms in elderly patients with depression and GDS-30 is unable to capture all the symptoms of depression among elderly in the Indian context. 30054249 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE We used the Mini International Neuropsychiatric Interview to diagnose major depression according to DSM-IV criteria and the GDS-15 to measure depression severity.<b>Results:</b> Excluding 174 individuals diagnosed with dementia, 54 (11.6%) of the remaining 457 individuals were diagnosed with LLD; 77.8% of which were female. 31791131 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE GDS-15 was a useful tool to classify stages of geriatric depression into either minor or major depressive disorder. 31470180 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The Geriatric Depression Scale-4 items (GDS-4) was used to assess the risk for depression occurrence. 31349566 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE After adjustment for the potential confounders, elderly men who had a vegetable-based diet had a higher rate of depression (OR[95%CI]: 1.62[1.07-2.46], 4.71[1.38-16.03]), more severe symptoms of depression (OR[95%CI]: 8.85[2.94-34.12]), and higher GDS scores (β[95%CI]: 1.46[0.70-2.22], 2.97[1.28-4.67]) than male participants who had a meat-based diet, but this was not the case in women. 30243198 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The Receiver Operating Characteristics analyses of HAD-D and GDS-5 using the diagnostic criteria of ICD-10 for depression as gold standard was performed. 31212233 2019
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE In a prospective cohort study the physical environment of 50 care homes were measured using the Sheffield Care Environment Assessment Matrix (SCEAM) and depressive symptoms of 510 residents measured using the Geriatric Depression Scale (GDS-15). 28535264 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The GDS and the GAI were found to be reliable and valid tools for detecting depression and anxiety in this sample. 29115201 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE Because partial measurement invariance was achieved suggesting that the tool as a whole functions similarly for older adults with and without cognitive impairment, professionals can be confident that the GDS-15 screens for depression as well in individuals with cognitive impairment as those without. 28612653 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE PD patients with EDS had worse non-motor (MDS-UPDRS Part-I, P < 0.001) and motor (MDS-UPRDS Part-II, P = 0.005) experiences of daily living, as well as worse autonomic (SCOPA-AUT, P < 0.0001) and cognitive (MoCA P = 0.05) function, depression (GDS, P = 0.002), and reduced caudate DAT ([<sup>123</sup>I]FP-CIT, P = 0.024) compared to PD patients without EDS. 29571867 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE The Geriatric Depression Scale (GDS-15) screened for depression. 30209651 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE All the participants underwent a comprehensive evaluation (including clinical examination, laboratory screening, neuroimaging, and cognitive and behavioral assessments) and they were assigned to three different groups on the basis of their cognitive functioning (normal, mild cognitive impairment, cognitive impairment) RESULTS: Two items showed uniform DIF but their differential functioning does not propagate to the GDS-15 total scores in such a way that a differential interpretation is needed LIMITATIONS: Whereas an advantage of the study is the large sample size, the relatively small size of the mild cognitive impairment group might reduce the stability of the present results CONCLUSIONS: Since a screening tool for elderly is intended to apply to everyone in the target population, the current findings support the clinical utility of the GDS-15 as screening tool for depression. 29156360 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE Sensitivity and specificity of the GDS-15 for identifying depression were 72% and 97% for younger adults and 86% and 91% for older adults, respectively. 30096593 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 Biomarker disease BEFREE GDS-4 and GDS-5 are not eligible for depression screening in Turkish older adults. 29560848 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE Generalized linear models estimated by generalized estimating equations examined associations between changes in cognitive diagnoses and symptoms on the Neuropsychiatric Inventory Questionnaire (NPI-Q) and Geriatric Depression Scale (GDS-15). 29614641 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE The MDP was not associated with the GDS-10 or GHQ-12 scores, or with clinically-diagnosed depression; however drinkers with a preference for wine showed an increased number of psychological distress symptoms (1.31 (1.03-1.66)). 30065286 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE The 30-item Geriatric Depression Scale (GDS-30) and the shorter GDS-15, GDS-5 and GDS-4 are recommended as depression screening tools for elderly individuals. 30518594 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.100 GeneticVariation disease BEFREE Depressive symptoms were measured with the Beck Depression Inventory-II (BDI-II) and the 30-item Geriatric Depression Scale (GDS-30); color vision was tested with the Farnsworth-Munsell 100 Hue Test (FMT); and olfactory function was tested with the Sniffin' Sticks Screening 12 Test. 29458280 2018